Persistent Asset Partners »

Maze Therapeatics shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Maze Therapeatics (MAZE) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Maze Therapeatics

Tip: Access up to 7 years of quarterly data

All positions including Maze Therapeatics held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maze Therapeatics by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $274k 6.6k 41.43

More positions owned by Persistent Asset Partners

Centene Corporation (CNC)
Molina Healthcare (MOH)
Anthem (ELV)
Intel Corporation (INTC)
Axt (AXTI)
Terns Pharmaceuticals (TERN)
Sandisk Corp (SNDK)
Abivax Sa Sponsored Ads (ABVX)
Johnson & Johnson (JNJ)
Brightspring Health Svcs (BTSG)
Viking Therapeutics Call Call Option
Viking Therapeutics (VKTX)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Nebius Group Shs Class A (NBIS)

View all positions for Persistent Asset Partners

Top funds holding Maze Therapeatics

Frazier Life Sciences Management
Trv Gp Iv
Deep Track Capital
Arch Venture Corp
BlackRock
AH Capital Management
Vanguard Group
VR Adviser
Alphabet
General Catalyst Group Management
Woodline Partners
TRV GP V
Logos Global Management
Bellevue Group
Marshall Wace

View all funds holding Maze Therapeatics